>>Hoping to prevent Congress from letting the government negotiate lower drug prices for millions of older Americans on Medicare, the pharmaceutical companies have been recruiting Democratic lobbyists, lining up allies in the Bush administration and Congress, and renewing ties with organizations of patients who depend on brand-name drugs.<<
Drug Industry Is on Defensive as Power Shifts - New York Times
Sunday, November 26, 2006
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment